I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
I Want to...
Evan Jacob Lipson, M.D.
Associate Professor of Oncology
Expertise: Clinical Trials, Immunotherapy, Medical Oncology, Melanoma
Research Interests: Melanoma; Immunotherapy
Request an Appointment
I live in Maryland
Request an appointment through My
I live outside of Maryland
I live outside of the United States
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Appointment Phone: 410-616-7660
401 N. Broadway
Baltimore, MD 21231 map
Sibley Memorial Hospital
Appointment Phone: 202-660-6500
5255 Loughboro Road, NW
Washington, DC 20016 map
Evan J. Lipson, M.D., is a medical oncologist at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology at Johns Hopkins University School of Medicine. Dr. Lipson established the Johns Hopkins Melanoma Program at Sibley in 2012 and opened the program's first clinical trial in the Washington, D.C. region in 2015. He is board certified in internal medicine and medical oncology.
Dr. Lipson has an expertise in melanoma and treatment of patients with cutaneous malignancies, specifically regarding the use of novel immunotherapies.
Dr. Lipson earned his undergraduate degree from the University of Maryland and his medical degree from Mount Sinai School of Medicine. He completed a residency in internal medicine at Johns Hopkins University School of Medicine, as well as a fellowship in medical oncology.
Dr. Lipson is the founder of SeizeTheDays.org, a non-profit organization that chronicles the stories of cancer patients who find interesting and meaningful ways to add life to their days. He is a member of The Johns Hopkins Hospital Multidisciplinary Cancer Committee, as well as the American Society for Clinical Oncology (ASCO), the Society for Melanoma Research, the Society for Immunotherapy of Cancer and the Eastern Cooperative Oncology Group.
Dr. Lipson is a nationally-recognized educator and lecturer about the clinical use of cancer immunotherapy, specifically regarding the management of immune-mediated drug toxicities, often in organ transplant recipients.
Dr. Lipson has contributed to numerous clinical trials, publications and presentations. His research focuses on investigating new therapies for patients with various stages of melanoma, ranging from preventing disease recurrence in high-risk patients to developing innovative drug therapies for patients with advanced disease. Dr. Lipson works to optimize combinations of immune-based therapies, such as cancer vaccines and immune checkpoint inhibitors, in order to achieve maximal anti-tumor activity. As a part of the Johns Hopkins Melanoma and Cancer Immunotherapy programs, Dr. Lipson also collaborates with basic and translational scientists in order to investigate biomarkers of drug efficacy. He is a peer reviewer for The Journal of the National Comprehensive Cancer Network, the ASCO Educational Book Expert Panel, the Journal for Immunotherapy of Cancer, Cancer Management and Research, Cancer Discovery, and Clinical Cancer Research.
- Associate Professor of Oncology
Departments / Divisions
- Medicine at Sibley Memorial Hospital
- Oncology - Medical Oncology
Centers & Institutes
- MD, Mount Sinai School of Medicine (2005)
- Johns Hopkins University School of Medicine / Medicine (2008)
- Johns Hopkins University School of Medicine / Oncology (2011)
- American Board of Internal Medicine / Internal Medicine (2008)
- American Board of Internal Medicine / Medical Oncology (2010)
Research & Publications
View Dr. Lipson's current research trials at Sibley Memorial Hospital here.
Selected PublicationsView all on Pubmed
Kaunitz GJ, Loss M, Rizvi H, Ravi S, Cuda JD, Bleich KB, Esandrio J, Sander I, Le DT, Diaz LA Jr, Brahmer JR, Drake CG, Hollmann TJ, Lacouture ME, Hellmann MD, Lipson EJ, Taube JM. "Cutaneous Eruptions in Patients Receiving Immune Checkpoint Blockade: Clinicopathologic Analysis of the Nonlichenoid Histologic Pattern." Am J Surg Pathol. 2017 Oct;41(10):1381-1389.
Kaunitz GJ, Cottrell TR, Lilo M, Muthappan V, Esandrio J, Berry S, Xu H, Ogurtsova A, Anders RA, Fischer AH, Kraft S, Gerstenblith MR, Thompson CL, Honda K, Cuda JD, Eberhart CG, Handa JT, Lipson EJ, Taube JM. "Melanoma subtypes demonstrate distinct PD-L1 expression profiles." Lab Invest. 2017 Sep;97(9):1063-1071. doi: 10.1038/labinvest.2017.64. Epub 2017 Jul 24.
Naidoo J, Cappelli LC, Forde PM, Marrone KA, Lipson EJ, Hammers HJ, Sharfman WH, Le DT, Baer AN, Shah AA, Albayda J, Manno RL, Haque U, Gutierrez AK, Bingham CO 3rd, Brahmer JR. "Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade." Oncologist. 2017 Jun;22(6):627-630. doi: 10.1634/theoncologist.2016-0390. Epub 2017 Jun 2. No abstract available.
Sunshine JC, Nguyen PL, Kaunitz GJ, Cottrell TR, Berry S, Esandrio J, Xu H, Ogurtsova A, Bleich KB, Cornish TC, Lipson EJ, Anders RA, Taube JM. "PD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody Comparison." Clin Cancer Res. 2017 Aug 15;23(16):4938-4944. doi: 10.1158/1078-0432.CCR-16-1821. Epub 2017 Apr 20.
Cho SY, Lipson EJ, Im HJ, Rowe SP, Gonzalez EM, Blackford A, Chirindel A, Pardoll DM, Topalian SL, Wahl RL. "Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point 18F-FDG PET/CT Imaging in Patients with Advanced Melanoma." J Nucl Med. 2017 Sep;58(9):1421-1428. doi: 10.2967/jnumed.116.188839. Epub 2017 Mar 30.
Activities & Honors
- Seize The Days
- Johns Hopkins Multidisciplinary Cancer Committee
- American Society for Clinical Oncology
- Society for Melanoma Research
- Society for Immunotherapy of Cancer
- Eastern Cooperative Oncology Group
Videos & Media
Recent News Articles and Media Coverage
How Does Immunotherapy Work?, Melanoma Research Alliance, Feb. 2, 2016
In The Beginning, Hopkins Medicine, Fall 2014
Keytrude Just One of a New Class of Cancer Drugs to Restart the Immune System, Healthline News, Sept. 10, 2014
New Skin Cancer Drug Approved, CNN, Jan. 31, 2012
'Seize the Days' Project Documents a Life with Cancer, WAMU 88.5, Jan. 6, 2012
Giving Patients a Way to Share Their Stories, Cancer.Net, April 4, 2011